Igc Pharma Inc share price logo

Igc Pharma Inc Share Price

NYSE: IGC

Small Cap

$0.29

+0.01

(+5.22%)

as on

Igc Pharma Inc Stock Performance

as on March 21, 2026 at 6:58 am IST

  • Day's Low

    $0.26
    $0.29
    downward going graph

    10.34%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.24
    $0.50
    downward going graph

    16.55%

    Downside

    71.90%

    Upside

    downward going graph

Igc Pharma Inc share price movements today

Previous Close
$0.27
Open
$0.27
Volume
1.4M
Day's Low - High
$0.26 - $0.29
52 Week Low - High
$0.24 - $0.50

Igc Pharma Inc Historical Returns

1 Month Return
+ 9.99 %
3 Month Return
-4.6 %
1 Year Return
-11.39 %
3 Year Return
-13.27 %
5 Year Return
-86.04 %

Igc Pharma Inc Stock Fundamentals & Key Indicators

Check Igc Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.2M

EPS (TTM)

-0.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.5M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

-83.34%

Igc Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Igc Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Igc Pharma Inc image
Igc Pharma Inc
BUY$27.2M-86.04%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Igc Pharma Inc Stock including INR - Dollar returns

The Igc Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Igc Pharma Inc investment value today

Current value as on today

₹1,00,070

Returns

₹70

(+0.07%)

Returns from Igc Pharma Inc Stock

₹9,375 (-9.38%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Igc Pharma Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Igc Pharma Inc. Average target price of $4

Igc Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Igc Pharma Inc.

What analysts predicted

92.75%UPSIDE

Target Price

$4

Current Price

$0.29

Analyzed by

5 Analysts

Target

$4.00

Igc Pharma Inc target price $4, a slight upside of 92.75% compared to current price of $0.29. According to 5 analysts rating.

Igc Pharma Inc Stock’s Investor Sentiment and Interest

Search interest for Igc Pharma Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Igc Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-2
-2
-2
-2
-1
-1
-1
-1
-2
EBITDA
-1
-2
-5
-2
-2
-1
-1
-1
-1
-1
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-5
-2
-2
-1
-1
-1
-1
-1
Income Tax Expense
0
0
-
0
-
-
-
-
-
-
Net Income
-2
-2
-5
-2
-2
-1
-1
-1
-1
-1
Net Profit Margin
-373.87%
-842.27%
-2739.71%
-977.97%
-874.26%
-416.75%
-711.67%
-362.73%
-487.50%
-953.40%

Igc Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
6
0
2
5
4
0
0
0
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-2
-1
-4
-6
-8
-15
-11
-9
-7
EBITDA
-1
-1
-1
-4
-6
-8
-14
-10
-9
-6
Interest Expense
0
0
0
-
-
-
0
0
-
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
-1
-4
-7
-8
-15
-11
-13
-7
Income Tax Expense
0
0
0
0
0
0
0
0
3
-
Net Income
-2
-1
-1
-4
-7
-8
-15
-11
-13
-7
Net Profit Margin
-44.10%
-321.69%
-81.44%
-80.08%
-179.64%
-981.18%
-3782.37%
-1263.01%
-966.54%
-560.27%

Igc Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-2
-5
-2
-2
-1
-1
-1
-1
-1
Operating Cash Flow
-1
-1
0
-1
0
-1
0
-1
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
2
0
0
2
0
0
0
0
3
Change in Cash
1
-1
0
0
0
-1
0
0
0

Igc Pharma Inc Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-1
-1
-4
-7
-8
-15
-11
-13
-7
Operating Cash Flow
-1
-1
-3
-8
-10
-7
-7
-5
-4
Investing Cash Flow
0
0
0
-9
3
0
0
0
0
Financing Cash Flow
0
3
27
0
14
4
0
3
4
Change in Cash
0
1
23
-18
7
-4
-7
-1
0

Igc Pharma Inc News & Key Events

    Insights on Igc Pharma Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, IGC stock has moved up by 10.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Igc Pharma Inc has experienced a drawdown of -14.7%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 12.2%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 22.7%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 330.0K → 191.0K (in $), with an average decrease of 21.2% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 3 quarters, -1.19M → -1.82M (in $), with an average decrease of 23.7% per quarter

    About Igc Pharma Inc

    igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
    OrganisationIgc Pharma Inc
    Headquarters10224 Falls Road, Potomac, MD, United States, 20854
    IndustryBiotechnology
    CEOMr. Ram Mukunda
    E-voting on sharesClick here to vote

    Key Management of Igc Pharma Inc

    Name

    Title

    Mr. Ram Mukunda

    Founder, President, CEO & Director

    Ms. Claudia Grimaldi

    VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director

    Benysh Qureshi Esq., M.B.A.

    Director of Operations

    Mr. Rohit Goel CPA, M.B.A.

    Director of Accounting & Senior Director

    Susana Salgar

    Sales Manager

    FAQs

    What is Igc Pharma Inc share price today?

    Igc Pharma Inc share price today is $0.29 as on at the close of the market. Igc Pharma Inc share today touched a day high of $0.29 and a low of $0.26.

    What is the 52 week high and 52 week low for Igc Pharma Inc share?

    Igc Pharma Inc share touched a 52 week high of $0.5 on and a 52 week low of $0.24 on . Igc Pharma Inc stock price today i.e. is closed at $0.29,which is 41.83% down from its 52 week high and 19.83% up from its 52 week low.

    What is Igc Pharma Inc's market capitalisation today?

    Igc Pharma Inc market capitalisation is $0.00T as on .

    How to invest in Igc Pharma Inc Stock (IGC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Igc Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Igc Pharma Inc Shares that will get you 5.1724 shares as per Igc Pharma Inc share price of $0.29 per share as on March 21, 2026 at 1:28 am IST.

    What is the minimum amount required to buy Igc Pharma Inc Stock (IGC) from India?

    Indian investors can start investing in Igc Pharma Inc (IGC) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹936.52 in Igc Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Igc Pharma Inc share’s latest price of $0.29 as on March 21, 2026 at 1:28 am IST, you will get 34.4828 shares of Igc Pharma Inc. Learn more about fractional shares .

    What are the returns that Igc Pharma Inc has given to Indian investors in the last 5 years?

    Igc Pharma Inc stock has given -86.04% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?